4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0001209191-19-031781
President and CEO sold 217,515 shares at an average $15.35 ($3,338,725)
- President and CEO acquired 250,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Polymeropoulos Mihael Hristos · President and CEO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-05-17 | Exercise or conversion : show line 1 in the form | +97,373 | $12.55 | $1,222,031 | 1,276,343 | D |
| 2019-05-17 | Sale : show line 2 in the form | −77,225 | $15.56 | $1,201,691 | 1,199,118 | D |
| 2019-05-20 | Exercise or conversion : show line 3 in the form | +73,608 | $12.55 | $923,780 | 1,272,726 | D |
| 2019-05-20 | Sale : show line 4 in the form | −67,418 | $15.12 | $1,019,084 | 1,205,308 | D |
| 2019-05-21 | Exercise or conversion : show line 5 in the form | +79,019 | $12.55 | $991,688 | 1,284,327 | D |
| 2019-05-21 | Sale : show line 6 in the form | −72,872 | $15.34 | $1,117,951 | 1,211,455 | D |
| Open-market sales · 217,515 sh · avg $15.35 · $3,338,725 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-05-17 | Exercise or conversion : show line 7 in the form Employee Stock Option (Right to Buy) | −97,373 | 152,627 | D |
| 2019-05-20 | Exercise or conversion : show line 8 in the form Employee Stock Option (Right to Buy) | −73,608 | 79,019 | D |
| 2019-05-21 | Exercise or conversion : show line 9 in the form Employee Stock Option (Right to Buy) | −79,019 | 0 | D |
Loading xslF345X03/doc4.xml…